Δημοσιεύσεις

Improvement of Calcinosis in Dermatomyositis With Intravenous Immunoglobulin

Sakellariou GT, Katsigianni I

J Clin Rheumatol 2024;30:e124

Effect of secukinumab on bone formation markers in patients with active ankylosing spondylitis

Sakellariou GT, Konsta M, Katsigianni I, Deligeorgakis D, Zisopoulos D, Vounotrypidis P

Int J Rheum Dis 2023;26:2603-2606

Follow-up imaging of SAPHO syndrome treated with denosumab

Sakellariou GT, Chaitidis N, Tsifountoudis I

Rheumatology (Oxford) 2023;62:e357-e358

Pustulotic arthro-osteitis (Sonozaky syndrome)

Sakellariou GT, Tsifountoudis I

Eur J Rheumatol 2022;9:180-181

A case of Behçet’s disease with scleromalacia perforans

G.Sakellariou, C.Berberidis, P.Vounotrypidis

Rheumatology(Oxford) 2005;44:258-260

Infusion related reactions to infliximab in patients with rheumatoid arthritis

G.T.Sakellariou, I.Chatzigiannis

J Rheumatol 2005;32:1411-1412

Infliximab infusions for persistent back pain in two patients with Schmorl’s nodes

G.T.Sakellariou, I.Chatzigiannis, I.Tsitouridis

Rheumatology(Oxford) 2005;44:1588-1590

Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra)

P.Vounotrypidis, G.T.Sakellariou, D.Zisopoulos, C.Berberidis

Rheumatology(Oxford) 2006;45:491-492

Bone density in young males with recently diagnosed inflammatory bowel disease

G.T.Sakellariou, J.Moschos, C.Berberidis, A.Mpoumponaris, S.Kadis, E.Molyvas, G.Kouklakis

Joint Bone Spine 2006;73:725-728

Intraarticular injection of infliximab

G.T.Sakellariou, G.Kakavouli, I.Chatzigiannis

J Rheumatol 2006;33:1912-1913

Long-term anti-TNFα therapy for ankylosing spondylitis in two patients with chronic HBV infection

G.T.Sakellariou, I.Chatzigiannis

Clin Rheumatol 2007;26:950-952

Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy

G.T.Sakellariou, P.Vounotrypidis, C.Berberidis

Clin Rheumatol 2007;26:1132-1133

No Effect of rosuvastatin in the zoledronate-induced acute-phase response

P.Makras, A.D.Anastasilakis, S.A.Polyzos, I.Bisbinas, G.T.Sakellariou, S.E.Papapoulos

Calcif Tissue Int 2011;88:402-408

Extensive calcinosis in lupus panniculitis

G.T.Sakellariou, D.Karanikolas, G.A.Kapetanos, K.Koutroumanidis, C.Berberidis

Arthritis Rheum 2011;63:2743

Efficacy of leflunomide addition in relation to prognostic factors for patients with active early rheumatoid arthritis failing to methotrexate in daily practice

G.T.Sakellariou, F.E.Sayegh, G.A.Kapetanos, C.Berberidis

Clin Rheumatol 2012;31:163-167

Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass

A.D.Anastasilakis, S.A.Polyzos, P.Makras, G.T.Sakellariou, I.Bisbinas, A.Gkiomisi, S.Delaroudis, S.Gerou, I.Ballaouri, D.Oikonomou, S.E.Papapoulos

Bone 2012;50:1130-1134

Central skeletal sarcoidosis: a case report with sustained remission only on methotrexate, and a literature review on the imaging approach, treatment, and assessment of disease activity

G.T.Sakellariou, A.D.Anastasilakis, D.Karanikolas, P.Vounotrypidis, C.Berberidis

Mod Rheumatol 2013;23:175-181

Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate

G.T.Sakellariou, F.E.Sayegh, A.D.Anastasilakis, G.A.Kapetanos

Rheumatol Int 2013;33:2917–2920

Disease-modifying anti-rheumatic drugs for refractory severe knee synovitis in patients with peripheral spondyloarthritis: efficacy and predictors of response

G.T.Sakellariou, F.E.Sayegh, A.D.Anastasilakis, I.Bisbinas, G.A.Kapetanos

Scand J Rheumatol 2013;42:369–372

Pachymeningitis in granulomatosis with polyangiitis: a case report and a review of the literature

G.T.Sakellariou, N.Kefala

Case Reports in Rheumatology 2013, ArticleID 840984

Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment

A.D.Anastasilakis, S.A.Polyzos, P.Makras, M.Savvides, G.T.Sakellariou, A.Gkiomisi, A.Papadopoulou, E.Terpos

Horm Metab Res 2014;46:145-149

Circulating periostin levels in patients with ankylosing spondylitis: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation

G.T.Sakellariou, A.D.Anastasilakis, I.Bisbinas, D.Oikonomou, S.Gerou, S.A.Polyzos, F.E.Sayegh

Rheumatology(Oxford) 2015;54:908-914

Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment

A.D.Anastasilakis, S.A.Polyzos, P.Makras, A.Gkiomisi, G.Sakellariou, M.Savvidis, A.Papatheodorou, P.Kokkoris, E.Terpos

Expert Opin Ther Targets 2015;19:299-306

Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk

E.Kenanidis, M.E.Potoupnis, P.Kakoulidis, A.Leonidou, G.T.Sakellariou, F.E.Sayegh, E.Tsiridis

Expert Opin Drug Saf 2015;14:1035-1053

Denosumab versus zoledronic acid in patients previously treated with zoledronic acid

A.D.Anastasilakis, S.A.Polyzos, A.Gkiomisi, Z.G.Saridakis, D.Digkas, I.Bisbinas, G.T.Sakellariou, A.Papatheodorou, P.Kokkoris, P.Makras

Osteoporos Int 2015;26:2521-2527

Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease

S.A.Polyzos, A.D.Anastasilakis, J.Kountouras, P.Makras, A.Papatheodorou, P.Kokkoris, G.T.Sakellariou, E.Terpos

J Bone Miner Metab 2016;34:447-456

Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers

A.D.Anastasilakis, S.A.Polyzos, Z.A.Efstathiadou, M.Savvidis, G.T.Sakellariou, A.Papatheodorou, P.Kokkoris, P.Makras

Metabolism 2015;64:1291-1297

The effect of smoking on clinical and radiographic variables, and acute phase reactants in patients with ankylosing spondylitis

G.T.Sakellariou, A.D.Anastasilakis, E.Kenanidis, M.Potoupnis, E.Tsiridis, M.Savvidis, N.Kartalis, F.E.Sayegh

Rheumatol Int 2015;35:2109-2114

Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters

G.T.Sakellariou, A.Iliopoulos, M.Konsta, E.Kenanidis, M.Potoupnis, E.Tsiridis, E.Gavana, F.E.Sayegh

Joint Bone Spine 2017;84:309-315

Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment

A.D.Anastasilakis, M.P.Yavropoulou, P.Makras, G.T.Sakellariou, F.Papadopoulou, S.Gerou, S.E.Papapoulos

Eur J Endocrinol 2017;176:677-683

Grab the bull by the horns

G.T.Sakellariou, I.Tsifountoudis, P.Athanassiou

J Clin Rheumatol 2018;24:149-150

Vascular acrosyndromes in young adult population. Definition of clinical symptoms and connections to joint hypermobility

P.Vounotrypidis, A.Pyrpasopoulou, G.T.Sakellariou, D.Zisopoulos, N.Kefala, D.I.Oikonomou, C.Stefanis, S.Aslanidis, C.Bermperidis, P.Pappas

Clin Rheumatol 2019;38:2925-2932

Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels

M.Konsta, G.T.Sakellariou, T.Rusman, P.P.Sfikakis, A.Iliopoulos, I.E. van der Horst-Bruinsma

Joint Bone Spine 2021;88:105-111

Psoriatic onycho-pachydermo periostitis (POPP): a case report treated successfully with IL-17 blockade and a literature review on characteristics, pathogenesis, and treatment

G.T.Sakellariou, I.Tsifountoudis, P.Vounotrypidis

Clin Rheumatol 2021 Apr 8 [in press]